Naseh Sigari

Naseh Sigari

Auto-generated profile, based on publicly available information

Naseh Sigari

Department of Internal Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
BNBahram Nikkhoo
Bahram Nikkhoo
MMMatin Mohammadi
Matin Mohammadi
SHSabah Hasani
Sabah Hasani
NSNaseh Sigari
Naseh Sigari
ABAryan Borhani
Aryan Borhani
KRKhaled Rahmani
Khaled Rahmani
Background: accompanied to the spreading of coronavirus disease 2019 (Covid-19) in the world, identifying factors related to the severity of the disease is one of the interests of physician and medical researchers. We hypothesized that interleukin 6 serum level is associated with severe outcome. Methods: In this longitudinal prospective cohort study we enrolled 208 confirmed COVID-19 patients who were admitted to the Tohid Hospital (Sanandaj, Iran). Patients were classified into two groups based on IL-6 value in the first day of admission, elevated (n = 107) or not elevated/normal (n = 101), and followed until the occurrence of final outcome (death or discharge from the hospital). Data were analyzed using univariate methods, Chi-squared and independent two sample T test. The relationship between the independent variables and our interesting outcomes were investigated by multiple linear and penalized logistic regression modeling. Results: A total of 208 patients, 51% female and mean age 53.6 ± 16.3 years, including 107 elevated and 101 non-elevated IL-6 patients, were followed. No significant difference was observed between the two groups in demographic and clinical characteristics. Although not significant, logistic regression results showed that the chance of death occurrence among patients with elevated IL-6 are 3.91 times higher. According to the multiple linear regression modeling, elevated IL-6 significantly increased the duration of hospital stay (P = 0.02). Frequency of ICU admission (P = 0.04) and mean of ICU stay (P = 0.8) are also higher in elevated IL-6 group. Conclusion: This study revealed that elevated IL-6 is significantly related to prolongation of hospital stay in Covid-19 patients. Although not significant, the occurrence of death among patients who had increased IL-6 in the time of admission was higher than patients with normal or lower serum levels of IL-6.


1 January 2016 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
NSNaseh Sigari
Naseh Sigari
AJAli Jalili
Ali Jalili
LMLaili Mahdawi
Laili Mahdawi
EGEbrahim Ghaderi
Ebrahim Ghaderi
MSMohammadi Shilan
Mohammadi Shilan
Sigari N, et al. Allergy Asthma Immunol Res. 2016 Sep;8(5):461-465. https://doi.org/10.4168/aair.2016.8.5.461

1 August 2009 in Saudi Medical Journal
Verified
Journal Article
Closed access
NSNaseh Sigari
Naseh Sigari
SMShilan Mohammadi
Shilan Mohammadi
OBJECTIVE: To define the clinical, radiographic, and bronchoscopic features, and to describe the occupations of the largest group of patients with anthracosis. METHODS: All patients who underwent flexible bronchoscopy at 2 Iranian hospitals (Imam Hospital [Tehran], and Tohid Hospital [Sanandaj]), Iran, between April 1982 and June 2006 were considered for inclusion in the study. The demographic data, clinical, and radiographic findings of anthracotic and anthracofibrotic patients were recorded. RESULTS: Of the 14300 patients, 487 cases of simple anthracosis, and 291 of anthracofibrosis were found. A total of 98.4% female patients were housewives, and 86.4% lived in rural areas. Of the male patients, 40.6% were farmers, 29.6% were manual workers, and 7.5% were miners. Of these, 96% of patients had abnormal chest radiography. On bronchoscopic examination, bilateral bronchial involvement was found in 62.5% of the patients. The condition was confined to the trachea in 0.38% of patients, the bronchi involved were the main bronchus in 37%, the lobar bronchi in 83.2%, and segmental bronchi in 35%. Bronchial narrowing and obstruction was observed in 37.4% of the patients. CONCLUSION: Anthracosis and anthracofibrosis are neglected conditions that are a common finding on routine bronchoscopic examination. Given the demographic findings, and a review of other reports from developing countries, exposure to combustion of biomass fuel in rural areas is a possible risk factor.

30 July 2015 in Medical Mycology
Verified
Journal Article
Open access
PDF file
SMShilan Mohammadi
Shilan Mohammadi
SKSoheila Khalilzadeh
Soheila Khalilzadeh
KGKoroush Goudarzipour
Koroush Goudarzipour
MHMaryam Hassanzad
Maryam Hassanzad
AMAlireza Mahdaviani
Alireza Mahdaviani
NSNaseh Sigari
Naseh Sigari
Background: Elevations in the number of immunocompromised patients in the past decade has lead to progressive increase in the incidence of Invasive Pulmonary Aspergillosis (IPA) among children; however, early diagnosis remains a challenge. Detection of galactomannan (GM) in the bronchoalveolar lavage (BAL) fluid appears to possess higher sensitivity and specificity than serum in immunocompromised adult patients but, it rarely has been investigated in pediatric patients. Methods: We performed a prospective case-control study to evaluate the efficacy of BAL GM in immunocompromised pediatric patients. Cases were subjects fulfilling the host factor criteria as defined by the EORTC/MSG and met established definitions for proven or probable IPA. Control group was patients with possible IPA in whom diagnoses other than IPA were confirmed and patients without risk factors of IPA who underwent bronchoscopy for other diagnostic purpose. Galactomannan testing was performed on BAL fluid samples using platelia Aspergillus seroassay. Results: Sixteen cases of IPA (4 proven, 12 probable) and 54 controls (6 possible IPA and 48 no IPA) were documented according to EORTC/MSG definitions. The sensitivity and positive predictive values of BAL GM using an OD index of ≥0.5 were 87.5% and 93.33% respectively. We found seven cases of IPA with negative serum GM while their BAL GM was positive. Conclusion: We found high diagnostic value of BAL GM in immunocompromised pediatric patients with IPA. The lower OD index is necessary in children to avoid missing the cases of IPA in children.

1 January 2011
Verified
Journal Article
Open access
NSNaseh Sigari
Naseh Sigari
NSNader Sigari
Nader Sigari
HGHooman Ghasri
Hooman Ghasri
EREzzat Rahimi
Ezzat Rahimi
SMShilan Mohammadi
Shilan Mohammadi
Asthma is a serious global health problem. The lack of a clinical gold standard for evaluation of asthma control, as well as inadequate recognition of uncontrolled asthma by patients and clinicians may contribute to this situation. The Asthma Control Test is an easy and reliable test. The aim of this study was to validate the Persian version of this test with regard to GINA2009 guidelines based on a specialist's rating of asthma control. Patients (n = 150) completed the Asthma Control Test. Pulmonary function was measured. A chest specialist rated asthma control in line with the Global Initiative for Asthma 2009 guidelines. Patients were divided into well controlled, partly controlled and uncontrolled groups in order to evaluate the reliability and validity of the ACT. The mean age was 41.68 years. The internal consistency reliability of 5-item ACT survey was 0.89%. There were no significant differences in ACT scores between different age, gender, educational status and inhabitancy groups. Between the groups with different GINA-based control levels, a significant difference in ACT score was noted in favor of an ACT-based discrimination of different states of asthma control (F = 305.3, P < 0.001). Patient group with poorer lung function (FEV1) scored significantly lower on the ACT than groups with better lung function (F = 6.82, P < 0.001). Differences in ACT score between treatment recommendation groups were significant (F = 50.54, P < 0.001). Statistically significant correlations were observed between ACT scores and GINA-based values of asthma control rating by a specialist (r = 0.86, p < 0.001) and treatment recommendations (r = 0.54, p < 0.001). Correlation between ACT score and percentage of FEV1 predicted was moderate (r = 0.39, P < 0.001). The Persian version of Asthma Control Test is a valid and reliable test for asthma control assessment.